Royal Bank of Canada’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
174,974
-10,759
| -6% | -$69.9K | ﹤0.01% | 3480 |
|
|
2025
Q1 | $1.47M | Buy |
185,733
+53,459
| +40% | +$424K | ﹤0.01% | 2880 |
|
|
2024
Q4 | $1.68M | Buy |
132,274
+95,625
| +261% | +$1.21M | ﹤0.01% | 2756 |
|
|
2024
Q3 | $511K | Buy |
36,649
+29,534
| +415% | +$412K | ﹤0.01% | 3672 |
|
|
2024
Q2 | $98K | Buy |
7,115
+3,409
| +92% | +$47K | ﹤0.01% | 4890 |
|
|
2024
Q1 | $61K | Sell |
3,706
-17,514
| -83% | -$288K | ﹤0.01% | 5008 |
|
|
2023
Q4 | $310K | Buy |
21,220
+11,499
| +118% | +$168K | ﹤0.01% | 4189 |
|
|
2023
Q3 | $119K | Buy |
9,721
+4,840
| +99% | +$59.2K | ﹤0.01% | 4786 |
|
|
2023
Q2 | $59K | Buy |
4,881
+2,077
| +74% | +$25.1K | ﹤0.01% | 5245 |
|
|
2023
Q1 | $37K | Sell |
2,804
-1,535
| -35% | -$20.3K | ﹤0.01% | 5392 |
|
|
2022
Q4 | $93K | Buy |
4,339
+2,832
| +188% | +$60.7K | ﹤0.01% | 5039 |
|
|
2022
Q3 | $30K | Buy |
1,507
+231
| +18% | +$4.6K | ﹤0.01% | 5487 |
|
|
2022
Q2 | $22K | Sell |
1,276
-1,266
| -50% | -$21.8K | ﹤0.01% | 5599 |
|
|
2022
Q1 | $25K | Sell |
2,542
-763
| -23% | -$7.5K | ﹤0.01% | 5997 |
|
|
2021
Q4 | $55K | Buy |
3,305
+1,929
| +140% | +$32.1K | ﹤0.01% | 5785 |
|
|
2021
Q3 | $33K | Buy |
+1,376
| New | +$33K | ﹤0.01% | 5878 |
|